No takes yet. Share an insight, caveat, or question.
Preclinical study demonstrates unimpeded magnetic resonance detection of 2-hydroxyglutarate in IDH1-mutant cancer cells, indicating potential for noninvasive tumor monitoring.
Miura et al. (2021) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: